Rankings
▼
Calendar
BBLG Q1 2024 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena
BBLG
Bone Biologics Corporation
$2M
Q1 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$903,536
Net Income
-$865,970
EPS (Diluted)
$-1.31
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$52,681
Balance Sheet
Total Assets
$4M
Total Liabilities
$164,626
Stockholders' Equity
$4M
Cash & Equivalents
$3M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$903,536
-$3M
+71.3%
Net Income
-$865,970
-$4M
+76.7%
← FY 2024
All Quarters
Q2 2024 →